Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.98% | +1.09% | -6.35% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.35% | 9.29B | |
-3.85% | 184B | |
-1.06% | 107B | |
-3.61% | 69.44B | |
+3.51% | 50.37B | |
+8.37% | 44.82B | |
+3.40% | 41.53B | |
+2.75% | 26.84B | |
+4.10% | 26.73B | |
+15.23% | 25.71B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Repligen : Reports Higher Q2 Earnings, Revenue From 2020 Levels, Raises Full-Year Outlook